KRAS and pancreatic neoplasm: This may explain why several of the human pancreatic cancer cell lines that are commonly used in research carry two mutant KRAS alleles (e.g., AsPC-1, MIA PaCa-2, Capan-1, KP-3; source NCI RAS Initiative).